Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Happy Life and PPD to Offer China Clinical Trial/Post-Marketing Services

publication date: Feb 21, 2019

Happy Life Tech of Beijing, an AI-based clinical/post-marketing CRO, teamed up with Pharmaceutical Product Development, a global clinical-stage CRO, to provide drug developers in China with clinical trial management and post-launch testing. The two companies expect their alliance will help to bring foreign drugs to China and, conversely, bring China drug products to global markets. The collaboration intends to provide clients with China services, including clinical study protocol design, site selection, patient recruitment and real-world evidence. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital